Stefan Hergenröder

This inventor holds 6 USPTO granted patents. Top assignees: Abbott Laboratories Corporation, Abbott Gmbh & Co Kg. Active years: 2002-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefan Hergenröder. Retrieved from https://idiyas.com/inventor/stefan-hergenrandoumlder

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 7(Granted Patents)

Company Filing History:

4 out of 4,188

Abbott Laboratories Corporation

Years Active: 2002-2004

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6686369 - &agr;-hydrdroxylic acid derivatives, their production and use (2004-02-03),

2. 6670367 - Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed ETA/ETB endothelin receptor antagonists (2003-12-30),

3. 6509341 - Carboxylic acid derivatives, carrying amido side-chains; production and use as endothelin receptor antagonists (2003-01-21),

4. 6469056 - Pharmaceutically active compounds, their preparation and use as ECE-inhibitors (2002-10-22),

5. 6448248 - Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists (2002-09-10),

6. 6358983 - Heterocyclically substituted &agr;-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists (2002-03-19),

Title: The Innovations of Stefan Hergenröder

Introduction

Stefan Hergenröder is a notable inventor based in Mainz, Germany. He has made significant contributions to the field of chemistry, particularly in the development of various chemical compounds. With a total of 6 patents to his name, Hergenröder has established himself as a key figure in his area of expertise.

Latest Patents

Among his latest patents are innovative works on α-hydroxylic acid derivatives, their production, and use. Additionally, he has developed azinyloxy and phenoxy-diaryl-carboxylic acid derivatives, which serve as mixed ETA/ETB endothelin receptor antagonists. These advancements highlight his commitment to pushing the boundaries of chemical research.

Career Highlights

Hergenröder has had a distinguished career, working with prominent companies such as Abbott Laboratories Corporation and Abbott GmbH & Co. KG. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking projects in the pharmaceutical and chemical industries.

Collaborations

Throughout his career, Hergenröder has collaborated with esteemed colleagues, including Wilhelm Amberg and Manfred Raschack. These partnerships have fostered a collaborative environment that has led to innovative solutions and advancements in their respective fields.

Conclusion

Stefan Hergenröder's contributions to the field of chemistry through his patents and collaborations demonstrate his dedication to innovation. His work continues to influence the industry and inspire future inventors.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]